ACTRN12623001337662尚未招募1 期
Concentrations of Thioguanine and its metabolite 6TGN in Blood and Rectal Tissue Samples in Patients with Refractory Ulcerative Proctitis Administered Thioguanine by Suppository
Douglas Pharmaceuticals0 个研究点目标入组 15 人开始时间: 2023年12月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with refractory ulcerative proctitis
排除标准
- •Unable to give informed consent
研究者
相似试验
已完成
不适用
Pharmacokinetics of 6-thioguanineISRCTN49579665VU University Medical Centre (VUMC) (The Netherlands)16
已完成
不适用
Pharmacokinetics of 6-thioguanine.Crohn's disease of ulcerative colitis (IBD).NL-OMON23696/A16
尚未招募
1 期
Rectal concentrations of thioguanine after enema administratioACTRN12622000934741Douglas Pharmaceuticals Ltd2
尚未招募
不适用
Effects of thiazolidinedione and biguanide in groups divided according to diabetic pathophysiologydiabetes mellitusJPRN-UMIN000005266Department of Metablic Medicine, Osaka University Hospital60
已完成
不适用
6-TGN levels (azathioprine drug monitoring) and markers of mucosal healing in patients with inflammatory bowel diseaseK50K51Crohn disease [regional enteritis]Ulcerative colitisDRKS00013246MHH OE681088